Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

From 2010 to 2020, breast cancer deaths among women ages 20–49 declined significantly across all breast cancer subtypes and ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

Findings demonstrate ATYR2810's anti-tumor activity and increased survival in a model of glioblastoma multiforme (GBM), a primary form of brain cancer.

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

The session follows the American Association for Cancer Research's prior call to action against executive orders that would ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...